Browse Category

NASDAQ:MIRA News 16 October 2025

MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine

MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine

Stock Soars on Breakthrough Announcement MIRA Pharmaceuticals’ stock price skyrocketed overnight on the back of surprising good news. The relatively obscure biotech – which trades on the Nasdaq Capital Market under ticker MIRA – closed Wednesday, Oct. 15 at $1.32 per sharebenzinga.com. That modest close (up less than 1% on the day) gave little hint of what was to come. After the market shut, MIRA stunned investors with a press release detailing remarkable lab results for its lead drug candidate. The reaction was immediate: shares surged 68.94% in after-hours trading, reaching $2.23benzinga.com. And the rally didn’t stop there. By Thursday
16 October 2025

Stock Market Today

Lam Research stock price jumps 8% as chip rally returns — what to watch next week

Lam Research stock price jumps 8% as chip rally returns — what to watch next week

7 February 2026
New York, Feb 7, 2026, 15:10 EST — Market closed. Lam Research Corp (LRCX.O) shares jumped 8.3% on Friday to close at $231.01. The stock was little changed after hours at $230.96. (MarketWatch) With U.S. markets shut for the weekend, the open question is whether Friday’s bounce sticks into Monday. Lam sells tools used to make semiconductors, so the stock often trades as a read-through on factory spending tied to AI data centers and memory. Friday’s risk-on swing pushed the Dow above 50,000 for the first time and lifted the PHLX semiconductor index — a barometer for chip stocks —
Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

Goldman Sachs stock jumps on Anthropic AI push — what to watch before Monday

7 February 2026
Goldman Sachs shares jumped 4.3% to $928.75 Friday after confirming it is working with AI startup Anthropic on internal “AI agents.” The stock’s rally helped lift the Dow above 50,000 for the first time. Delayed U.S. jobs and inflation data are due midweek and could affect rate expectations. Goldman also filed for new structured notes tied to the Russell 2000 and S&P 500.
Go toTop